Nexnos Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 1.91 Cr
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.25 Cr
- Revenue Growth 373.12%
- Profit Growth 2026.66%
- Ebitda -460.60%
- Net Worth 46.84%
- Total Assets 73.46%
About Nexnos Pharma
Nexnos Pharma Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 August 2007 and has a history of 17 years and seven months. Its registered office is in Chittorgarh, Rajasthan, India.
The Corporate was formerly known as Asnani Brokers Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.91 Cr.
The company currently has active open charges totaling ₹2.25 Cr.
Vinod Asnani, Kamal Asnani, Rajesh Peswani, and Two other members serve as directors at the Company.
Company Details
- Location
Chittorgarh, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100RJ2007PTC024845
- Company No.
024845
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Healthcare
Pharma
Who are the key members and board of directors at Nexnos Pharma?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Asnani  | Director | 14-Aug-2007 | Current |
| Kamal Asnani | Director | 14-Aug-2007 | Current |
| Rajesh Peswani | Director | 26-Mar-2024 | Current |
| Rameshchandra | Director | Current | |
| Ashish Agrawal | Director | 03-May-2023 | Current |
Financial Performance of Nexnos Pharma.
Nexnos Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 373.12% increase. The company also saw a substantial improvement in profitability, with a 2026.66% increase in profit. The company's net worth Soared by an impressive increase of 46.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexnos Pharma?
In 2023, Nexnos Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Asnani Stock Broker Private Limited
Vinod Asnani and Kamal Asnani are mutual person
Nexifi Global Capital Private LimitedVinod Asnani is a mutual person
- Skytouch Capital Private Limited
Kamal Asnani is a mutual person
- Euro Exports Private Limited
Rajesh Peswani is a mutual person
Charges (Loans)
Open Charges
₹2.25 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 2.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2024 | Others | ₹2.25 Cr | Open |
How Many Employees Work at Nexnos Pharma?
Unlock and access historical data on people associated with Nexnos Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexnos Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexnos Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Nexnos Pharma
Recent activity within the organization
- Annual General Meeting
Nexnos Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge with Others amounted to Rs. 2.25 Cr with Charge ID 100936082 was registered on 19 Jun 2024.
- Balance Sheet
Nexnos Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur.
- Director Appointment
Rajesh Peswani was appointed as a Director was appointed as a Director on 26 Mar 2024 & has been associated with this company since 1 year 2 days .
- Director Appointment
Ashish Kumar Agrawal was appointed as a Director was appointed as a Director on 03 May 2023 & has been associated with this company since 1 year 10 months .
- Director Appointment
Vinod Asnani was appointed as a Director was appointed as a Director on 14 Aug 2007 & has been associated with this company since 17 years 7 months .
Frequently asked questions
What is the Incorporation or founding date of Nexnos Pharma Private Limited?
Nexnos Pharma Private Limited was incorporated on 14 Aug 2007.
What is authorized share capital and paid-up capital of Nexnos Pharma Private Limited?
The authorized share capital of Nexnos Pharma Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 1.91 Cr.
Who are the current board members & directors of Nexnos Pharma Private Limited?
Currently 5 directors are associated with Nexnos Pharma Private Limited.
- Vinod Asnani
- Kamal Asnani
- Rajesh Peswani
- Rameshchandra
- Ashish Kumar Agrawal
What is the registered address of Nexnos Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Nexnos Pharma Private Limited is 103 Pratap Nagar, Sindhi Colony India, Chittorgarh, Rajasthan, 312001.
What is the corporate identification number (CIN) and company number of Nexnos Pharma Private Limited?
The corporate identification number (CIN) of Nexnos Pharma Private Limited is U24100RJ2007PTC024845 and the company number is 024845 as per Ministry of Corporate Affairs (MCA).
What is the official website of Nexnos Pharma Private Limited?
The Official website of Nexnos Pharma Private Limited is https://www.asnanionline.com
What has been the recent revenue trend for Nexnos Pharma Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Nexnos Pharma Private Limited has risen by 373.12%.
What change has been observed in the net worth of Nexnos Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Nexnos Pharma Private Limited has experienced an upsurge of 46.84%.
What are the total open charges for Nexnos Pharma Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Nexnos Pharma Private Limited amount to ₹ 2.25 Cr.
When was the last Balance Sheet of Nexnos Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Nexnos Pharma Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
R
RameshchandraDirector